Changing The Landscape Of Cognitive Disease

The Future Of Diagnostics, Now

introducing Lucent Diagnostics, a commercial brand of Quanterix, created to commercially deliver revolutionary tools that aid in the earlier detection of cognitive disease. Powered by ultra-sensitive Simoa^TM technology, Lucent Diagnostics bridges the gap between research and clinical use by offering products and services designed specifically to meet the separate needs of institutions and healthcare providers. With more than a decade of proven success within the neurology research space, supported by thousands of publications and partnerships, Quanterix aims to directly impact the landscape of cognitive disease through its commercial brand, Lucent Diagnostics